News Release

New 'Kessinger lab' marks continued expansion of the MMRI

Dr. Chase Kessinger promoted to assistant professor, underscoring the importance of deep vein thrombosis and pulmonary embolism research at the Masonic Medical Research Institute

Business Announcement

Masonic Medical Research Institute

MMRI logo

image: MMRI logo view more 

Credit: MMRI

For Immediate Release:                                                                                    
December 1, 2022

UTICA, NY — Chase Kessinger, Ph.D., was recently promoted to Assistant Professor at the Masonic Medical Research Institute (MMRI), adding a new lab to the growing Institute. Dr. Kessinger’s research utilizes imaging techniques to study a range of interests, including deep vein thrombosis, pulmonary embolism, heart failure, atherosclerosis, and other cardiovascular diseases. He joined the MMRI in 2018 as an instructor in the lab of Dr. Jason McCarthy, an Associate Professor whose research focuses on nanoparticle drug delivery platforms and fluorescence imaging technologies. Dr. Kessinger also manages the histology, imaging, and surgery core facilitates at MMRI.

Before joining the MMRI team, Dr. Kessinger was an instructor at Massachusetts General Hospital (MGH) and Harvard Medical School. He did his postdoctoral fellowship training at MGH, working with Dr. Farouc A. Jaffer at the Cardiovascular Research Center. Dr. Kessinger earned his Ph.D. in Cancer Biology from the University of Texas Southwestern Medical School in Dallas and is a graduate of Texas A&M University with a B.S. in Microbiology.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.